The Feds & Weight Loss
By J. Brian Keith
Current info about weight loss and the federal government is not always the easiest thing to locate. Fortunately, this report includes the latest weight loss and the federal government info available.

It seems like new information is discovered about something every day. And the topic of weight loss and the federal government is no exception. Keep reading to get more fresh news about weight loss.

You may be surprised what the federal government has to say about weight loss. The National Institutes of Health has some interesting ideas about what it takes to trim the fat. You may find that a number of these ideas conflict with what you've been hearing in the popular press.

For instance, you may have read that consuming red meat makes it more difficult for you to shed pounds. Actually, lean meat can be a critical component of a diet. While red meat, chicken, and pork may have cholesterol and saturated fat, they also have important minerals such as iron and zinc. However, when eating meat, you should try to make sure that it is low in fat. You can choose from sirloin tip, round steak, and flank steak. You should also be aware of proper portion sizes-the average portion should be the size of a billfold folded over.

You may have heard that dairy products are fattening. However, low-fat milk, yogurt, and cheese have all the nutrients of whole milk products, with fewer calories and less fat. Dairy products are particularly beneficial for their calcium, protein, and vitamin D content. According to federal guidelines, children, teenagers, and senior citizens should have three servings of milk products each day, while adults age 19 to 49 should have two helpings daily. A serving would consist of a single cup of milk or yogurt, or 1 ½ ounces of cheese. If you have trouble digesting milk products, consider lactose-free items. You may also be able to get your calcium from juice or salmon, and your vitamin D from juice or cereal.

The federal government maintains that becoming a vegetarian will not automatically make you lose weight. However, studies have indicated that vegetarians do ingest fewer calories than meat-eaters

NOX-E36 Multiple Ascending Dose Study in Healthy Volunteers and Patients With Type 2 Diabetes Mellitus
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: NOX-E36;   Drug: NOX-E36<br/><b>Sponsors</b>:   Noxxon Pharma AG;   Profil Institut für Stoffwechselforschung GmbH<br/><b>Not yet recruiting</b> - verified March 2010
Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism
<b>Conditions</b>:   Type 2 Diabetes;   Hypogonadism<br/><b>Intervention</b>:   Drug: Testosterone<br/><b>Sponsor</b>:   Tameside Hospital NHS Foundation Trust<br/><b>Not yet recruiting</b> - verified November 2008
Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With Diabetes
<b>Condition</b>:   Type 1 Diabetes Mellitus<br/><b>Interventions</b>:   Behavioral: Diabetes related psychological counseling and education;   Device: Continuous Glucose Monitor<br/><b>Sponsors</b>:   University Hospital Case Medical Center;   National Institute of Mental Health (NIMH)<br/><b>Not yet recruiting</b> - verified March 2010
Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: linagliptin;   Drug: placebo<br/><b>Sponsor</b>:   Boehringer Ingelheim Pharmaceuticals<br/><b>Recruiting</b> - verified March 2010
To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: AZD1656;   Drug: Gemfibrozil;   Drug: Placebo<br/><b>Sponsor</b>:   AstraZeneca<br/><b>Not yet recruiting</b> - verified March 2010
Effects of Caloric Restriction Alone Versus Postoperative Caloric Restriction Following Bariatric Surgery on Glucose Metabolism in Patients With Diabetes Mellitus
<b>Conditions</b>:   Obesity;   Bariatric Surgery;   Morbid Obesity;   Diabetes Mellitus Type 2;   Diet Therapy<br/><b>Interventions</b>:   Procedure: Roux-en-Y Gastric Bypass;   Behavioral: Caloric Restriction<br/><b>Sponsor</b>:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified February 2010
Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: AZD1656;   Drug: Pioglitazone<br/><b>Sponsor</b>:   AstraZeneca<br/><b>Recruiting</b> - verified March 2010
The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: Canagliflozin 100 mg;   Drug: Placebo/sitagliptin 2x50 mg;   Drug: Canagliflozin 300 mg<br/><b>Sponsor</b>:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.<br/><b>Recruiting</b> - verified March 2010
Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral Nutrition
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: INSULIN GLARGINE;   Drug: INSULIN GLULISINE<br/><b>Sponsor</b>:   Sanofi-Aventis<br/><b>Recruiting</b> - verified March 2010
Lifestyle Intervention to Limit Excessive Weight Gain During Pregnancy in Minority Women
<b>Conditions</b>:   Pregnancy;   Weight Gain<br/><b>Interventions</b>:   Behavioral: Lifestyle Intervention group;   Behavioral: Standard of Care<br/><b>Sponsor</b>:   Emory University<br/><b>Not yet recruiting</b> - verified March 2010
Comparing Google With A Focused Diabetes Search Engine
<b>Condition</b>:   Diabetes<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Beth Israel Deaconess Medical Center<br/><b>Recruiting</b> - verified March 2010
Continuous Glucose Monitoring in Type 2 Diabetes Mellitus
<b>Condition</b>:   Diabetic Vascular Complications<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Winthrop University Hospital<br/><b>Recruiting</b> - verified March 2010
Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin glargine;   Drug: NN1250;   Drug: insulin aspart<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Recruiting</b> - verified March 2010
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
<b>Conditions</b>:   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2;   Diabetic Polyneuropathy<br/><b>Interventions</b>:   Drug: SB-509;   Other: Saline<br/><b>Sponsors</b>:   Sangamo Biosciences;   Juvenile Diabetes Research Foundation<br/><b>Recruiting</b> - verified March 2010
A Culturally Tailored Lifestyle Intervention to Prevent Diabetes in South Asians
<b>Conditions</b>:   Diabetes;   Obesity<br/><b>Intervention</b>:   Behavioral: Lifestyle Intervention Classes<br/><b>Sponsors</b>:   Emory University;   American Diabetes Association;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Not yet recruiting</b> - verified January 2010
Corneal Endothelial Changes Associated With Phacoemulsification in Diabetes Mellitus Type II
<b>Conditions</b>:   Diabetes;   Cataract<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Frederiksberg University Hospital<br/><b>Completed</b> - verified August 2009
Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes Mellitus
<b>Condition</b>:   Hypertension<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Abbott<br/><b>Completed</b> - verified March 2010
Impact of Computerized Decision Support on Racial/Ethnic Disparities in Hypertension Outcomes
<b>Condition</b>:   Hypertension<br/><b>Intervention</b>:   Other: Computerized reminders on hypertension intensification<br/><b>Sponsors</b>:   Brigham and Women's Hospital;   Robert Wood Johnson Foundation<br/><b>Not yet recruiting</b> - verified March 2010
Intraarterial Infusion of Autologous Mesenchymal Stem Cells From Adipose Tissue in Diabetic Patients With Chronic Critical Limb Ischemia
<b>Conditions</b>:   Diabetes;   Limb Ischemia<br/><b>Interventions</b>:   Other: Autologous mesenchymal stem cells from adipose tissue.;   Other: Autologous mesenchymal stem cells from adipose tissue.;   Other: Autologous mesenchymal stem cells from adipose tissue.<br/><b>Sponsors</b>:   Fundacion Progreso y Salud, Spain;   Carlos III Health Institute<br/><b>Recruiting</b> - verified January 2010
Reducing HIV Risk Among Mexican Youth
<b>Conditions</b>:   HIV/AIDS;   STD;   Sexual Behavior<br/><b>Interventions</b>:   Behavioral: Adolescent Safer Sex Intervention;   Behavioral: Parent Safer Sex Communication Intervention;   Other: Adolescent Health Promotion Control Condition;   Other: Parent Health Promotion Control Condition<br/><b>Sponsors</b>:   University of Michigan;   National Institute of Nursing Research (NINR)<br/><b>Completed</b> - verified March 2010
Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects
<b>Conditions</b>:   Genotype;   Pharmacokinetic<br/><b>Intervention</b>:   Drug: Glipizide<br/><b>Sponsors</b>:   Chinese Academy of Sciences;   The First Affiliated Hospital of Lanzhou University<br/><b>Completed</b> - verified November 2009
Role of Vitagliptin and Vitamin D in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)
<b>Condition</b>:   Non-Alcoholic Fatty Liver Disease<br/><b>Interventions</b>:   Drug: Galvus (vitagliptin);   Drug: Galvus + vitamin D<br/><b>Sponsor</b>:   Ziv Hospital<br/><b>Not yet recruiting</b> - verified March 2010
Adolescent Cooking and Eating Study
<b>Condition</b>:   Polycystic Ovary Syndrome<br/><b>Intervention</b>:   Behavioral: Nutrition Education, Dietary Counseling, and Cooking<br/><b>Sponsors</b>:   Children's Hospital Boston;   Thrasher Research Fund<br/><b>Not yet recruiting</b> - verified March 2010
Midfoot Fusion Bolt (MFB) in the Early Stage of Diabetic-neuropathic Charcot Feet
<b>Conditions</b>:   Diabetes Mellitus 1 or 2;   Midfoot Charcot Neuroarthropathy<br/><b>Interventions</b>:   Procedure: Surgery with Midfoot Fusion Bolt;   Procedure: Cast treatment<br/><b>Sponsor</b>:   AO Clinical Investigation and Documentation<br/><b>Not yet recruiting</b> - verified March 2010
An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Intervention</b>:   Drug: repaglinide<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Not yet recruiting</b> - verified February 2010
Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment.
<b>Condition</b>:   Diabetes Type 2<br/><b>Interventions</b>:   Drug: Insulin-Levemir;   Drug: Exenatide-Bayetta;   Drug: Insulin-Levemir and Exenatide-Bayetta;   Device: SenseWear Pro3® armband;   Device: DexCom CGM<br/><b>Sponsors</b>:   Novo Nordisk;   BodyMedia<br/><b>Recruiting</b> - verified June 2009
Effects of a Spiced Meat Patty on Inflammation in Men With Type 2 Diabetes
<b>Condition</b>:   Type II Diabetes Mellitus<br/><b>Intervention</b>:   Other: Spice polyphenols<br/><b>Sponsor</b>:   University of California, Los Angeles<br/><b>Recruiting</b> - verified February 2010
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin glargine<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Recruiting</b> - verified March 2010
Corneal Endothelium Morphology and Central Thickness in Type II Diabetes Mellitus and Normal Subjects
<b>Condition</b>:   Corneal Dystrophy<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Frederiksberg University Hospital<br/><b>Recruiting</b> - verified January 2010
A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents
<b>Condition</b>:   Type 2 Diabetes<br/><b>Interventions</b>:   Drug: exenatide;   Drug: Other antidiabetic therapies;   Other: No diabetes therapy<br/><b>Sponsors</b>:   Amylin Pharmaceuticals, Inc.;   Eli Lilly and Company<br/><b>Completed</b> - verified February 2010
Ranibizumab for Edema of the mAcula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
<b>Condition</b>:   Diabetic Macular Edema<br/><b>Interventions</b>:   Drug: Ranibizumab;   Drug: ranibizumab<br/><b>Sponsors</b>:   Johns Hopkins University;   Juvenile Diabetes Research Foundation<br/><b>Recruiting</b> - verified February 2010
BASAAL PLUS - Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: Insulin glulisine;   Drug: Insulin glargine;   Drug: Premixed insulin (Insulin Aspart 30/70 )<br/><b>Sponsor</b>:   Sanofi-Aventis<br/><b>Recruiting</b> - verified March 2010
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia
<b>Conditions</b>:   Schizophrenia;   Schizoaffective Disorders;   Schizophreniform Disorders<br/><b>Interventions</b>:   Drug: Pravastatin;   Drug: Placebo<br/><b>Sponsors</b>:   Massachusetts General Hospital;   Stanley Medical Research Institute<br/><b>Not yet recruiting</b> - verified March 2010
DETECT-Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment
<b>Condition</b>:   Cardiovascular Diseases<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Dresden University of Technology;   Johann Wolfgang Goethe University Hospitals;   Max-Planck-Institute of Psychiatry;   University of Magdeburg;   Medical University of Graz;   Universitätsklinikum Hamburg-Eppendorf<br/><b>Completed</b> - verified February 2010
Healthy Homes/Healthy Kids_5-9
<b>Conditions</b>:   Obesity;   Injury<br/><b>Interventions</b>:   Behavioral: Healthy Eating/Physical Activity;   Behavioral: Safety/Injury Prevention<br/><b>Sponsors</b>:   HealthPartners Research Foundation;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   University of Washington;   University of Minnesota School of Public Health<br/><b>Not yet recruiting</b> - verified March 2010
Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients
<b>Condition</b>:   Hypertension<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Abbott;   McKesson Canada<br/><b>Recruiting</b> - verified February 2010
Pilot Pharmacokinetic Study of Daily Versus Monthly High-Dose Cholecalciferol Supplementation
<b>Condition</b>:   Healthy Volunteers<br/><b>Interventions</b>:   Dietary Supplement: Single High Dose Cholecalciferol;   Dietary Supplement: Daily Dose Cholecalciferol<br/><b>Sponsor</b>:   Mayo Clinic<br/><b>Recruiting</b> - verified March 2010
Effects of N-acetylcysteine on Diabetic Foot Oxygenation
<b>Condition</b>:   Foot Ulcer, Diabetic<br/><b>Intervention</b>:   Drug: N-acetylcysteine<br/><b>Sponsor</b>:   University of Turin, Italy<br/><b>Completed</b> - verified February 2010
Self Management and Reminders With Technology: SMART Appraisal of an Integrated Personal Health Record (PHR)
<b>Condition</b>:   Cardiovascular Risk<br/><b>Interventions</b>:   Other: SMART PHR;   Other: usual care<br/><b>Sponsors</b>:   University of Pittsburgh;   Agency for Healthcare Research and Quality (AHRQ)<br/><b>Not yet recruiting</b> - verified March 2010
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use NSAIDs and/or Colchicines.
<b>Condition</b>:   Acute Gout<br/><b>Interventions</b>:   Drug: ACZ885;   Drug: Triamcinolone acetonide<br/><b>Sponsor</b>:   Novartis Pharmaceuticals<br/><b>Not yet recruiting</b> - verified March 2010
Documentation of Humira in Psoriasis Patients in Routine Clinical Practice
<b>Condition</b>:   Moderate to Severe Plaque Psoriasis<br/><b>Intervention</b>:   Biological: adalimumab (Humira)<br/><b>Sponsor</b>:   Abbott<br/><b>Recruiting</b> - verified February 2010
Healthy Homes/Healthy Kids Preschool
<b>Condition</b>:   Obesity<br/><b>Interventions</b>:   Behavioral: Busy Bodies/Better Bites;   Behavioral: Healthy Spots/Safe Tots<br/><b>Sponsors</b>:   HealthPartners Research Foundation;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Not yet recruiting</b> - verified March 2010
Study of Ischemic Colitis Compared to Other Diagnoses in Patients With Lower Gastrointestinal Bleeding
<b>Condition</b>:   Colitis, Ischemic<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   University of California, Los Angeles;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Completed</b> - verified December 2009
Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices
<b>Condition</b>:   Esophageal Varices<br/><b>Intervention</b>:   Device: Capsule endoscopy, Esophagogastroduodenoscopy<br/><b>Sponsors</b>:   University of California, Los Angeles;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Completed</b> - verified June 2008


and tend to have lower body mass indexes. However, even as a vegetarian, you have to watch your intake of high-calorie food. Also, as a vegetarian you will have to find ways to ensure that you get plenty of iron, protein, calcium, and vitamin D, which might otherwise be missing from your diet. As a result, it is important that you select vegetarian entrees that are not only low-fat, but high in nutrition. For instance, spinach will give you iron, broccoli can provide calcium, milk offers vitamin D, eggs provide vitamin B12, whole grains offer zinc, and eggs give you protein.

You might have been told that you should not eat nuts if you want to shed pounds. In actuality, a small amount of nuts can be an ingredient of your weight loss plan. While nuts are, generally speaking, high in fat, the fat is considered a healthy kind that does not harm the arteries. Nuts can provide you with not only protein, but fiber and magnesium as well. But it is important that you eat nuts in moderation. This means consuming only about a third of a cup or less per day.

Federal health officials are firm on the idea that fasting is not a good way to lose weight. It is far better to eat regular meals, although you might opt for smaller meals than you might ordinarily choose eaten more frequently. Meals help to kick-start your metabolism, enabling it to thrive throughout the day.

If you are skeptical about a particular weight loss claim, you can check the Federal Trade Commission's website at www.ftc.gov/bcp/conline/features/wgtloss.htm for the information you need. Also, you might benefit from discussing your concerns with a registered dietician. In order to locate one in your geographical area, log onto the American Dietetic Association website at www.eatright.org/Public/PublicDieticianDisclaimerAdvanced.htm.

Does the federal government have all the answers when it comes to weight loss? Perhaps not. But it is clear that the feds have a great deal of research to back up their claims. Therefore, you should carefully consider the nutritional information that comes from federal sources. The federal government is interested in having a healthy populace; it has nothing to gain by promoting specific weight loss programs. Therefore, you can be sure that the information that you are getting from federal health authorities is information you can trust. And it could make a great deal of difference, as far as your personal weight is concerned.

The day will come when you can use something you read about here to have a beneficial impact. Then you'll be glad you took the time to learn more about Weight Loss and the federal government.

Author J. Brian Keith is a proud contributing author forWeight Loss and Dieting,Home Exercise Equipment and enjoys writing about many different topics. Please visit my other web sitesfor Diet and Health Articles andFree Photo Sharing.

Here are some more diabetes articles...